{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:15:01Z","timestamp":1763036101026,"version":"3.32.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,6,1]]},"DOI":"10.1093\/carcin\/bgi314","type":"journal-article","created":{"date-parts":[[2005,12,17]],"date-time":"2005-12-17T01:27:34Z","timestamp":1134782854000},"page":"1251-1256","source":"Crossref","is-referenced-by-count":58,"title":["Prostaglandin-endoperoxide synthase 2 ( PTGS2 ) gene polymorphisms and risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China"],"prefix":"10.1093","volume":"27","author":[{"given":"Lori C.","family":"Sakoda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Tang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingshu E.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip S.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asif","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Chang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing-Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-Quan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bai-He","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hope","family":"Cohen-Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith","family":"Yeager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Welch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Chanock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Joseph F.","family":"Fraumeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann W.","family":"Hsing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,12,16]]},"reference":[{"key":"key\n\t\t\t\t20171011213207_B1","doi-asserted-by":"crossref","unstructured":"Hsing,A.W., Rashid,A., Devesa,S.S. and Fraumeni,J.F. Jr ( 2006 ) Biliary tract cancer. In Schottenfeld,D. and Fraumeni,J.F. Jr (eds) Cancer Epidemiology and Prevention . 3rd ed. Oxford University Press, NY (in press).","DOI":"10.1093\/acprof:oso\/9780195149616.003.0040"},{"key":"key\n\t\t\t\t20171011213207_B2","doi-asserted-by":"crossref","unstructured":"Wistuba,I.I. and Gazdar,A.F. ( 2004 ) Gallbladder cancer: lessons from a rare tumour. Nat. Rev. Cancer , 4 , 695 \u2013706.","DOI":"10.1038\/nrc1429"},{"key":"key\n\t\t\t\t20171011213207_B3","unstructured":"Coogan,P.F., Rosenberg,L., Palmer,J.R., Strom,B.L., Zauber,A.G., Stolley,P.D. and Shapiro,S. ( 2000 ) Nonsteroidal anti-inflammatory drugs and risk of digestive cancers at sites other than the large bowel. Cancer Epidemiol. Biomarkers Prev. , 9 , 119 \u2013123."},{"key":"key\n\t\t\t\t20171011213207_B4","doi-asserted-by":"crossref","unstructured":"Gonzalez-Perez,A., Garcia Rodriguez,L.A. and Lopez-Ridaura,R. ( 2003 ) Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis. BMC Cancer , 3 , 28 .","DOI":"10.1186\/1471-2407-3-28"},{"key":"key\n\t\t\t\t20171011213207_B5","doi-asserted-by":"crossref","unstructured":"Hsing,A.W., Gao,Y.T., Devesa,S.S., Jin,F. and Fraumeni,J.F. Jr ( 1998 ) Rising incidence of biliary tract cancers in Shanghai, China. Int. J. Cancer , 75 , 368 \u2013370.","DOI":"10.1002\/(SICI)1097-0215(19980130)75:3<368::AID-IJC7>3.0.CO;2-0"},{"key":"key\n\t\t\t\t20171011213207_B6","doi-asserted-by":"crossref","unstructured":"Liu,E., Sakoda,L.C., Gao,Y. et al . ( 2005 ) Aspirin use and risk of biliary tract cancer: a population-based study in Shanghai, China. Cancer Epidemiol. Biomarkers Prev. , 14 , 1315 \u20131318.","DOI":"10.1158\/1055-9965.EPI-05-0032"},{"key":"key\n\t\t\t\t20171011213207_B7","doi-asserted-by":"crossref","unstructured":"Zha,S., Yegnasubramanian,V., Nelson,W.G., Isaacs,W.B. and De Marzo,A.M. ( 2004 ) Cyclooxygenases in cancer: progress and perspective. Cancer Lett. , 215 , 1 \u201320.","DOI":"10.1016\/j.canlet.2004.06.014"},{"key":"key\n\t\t\t\t20171011213207_B8","doi-asserted-by":"crossref","unstructured":"Ghosh,M., Kawamoto,T., Koike,N. et al . ( 2000 ) Cyclooxygenase expression in the gallbladder. Int. J. Mol. Med. , 6 , 527 \u2013532.","DOI":"10.3892\/ijmm.6.5.527"},{"key":"key\n\t\t\t\t20171011213207_B9","unstructured":"Asano,T., Shoda,J., Ueda,T. et al . ( 2002 ) Expressions of cyclooxygenase-2 and prostaglandin E-receptors in carcinoma of the gallbladder: crucial role of arachidonate metabolism in tumor growth and progression. Clin. Cancer Res. , 8 , 1157 \u20131167."},{"key":"key\n\t\t\t\t20171011213207_B10","doi-asserted-by":"crossref","unstructured":"Kawamoto,T., Shoda,J., Asano,T., Ueda,T., Furukawa,M., Koike,N., Tanaka,N., Todoroki,T. and Miwa,M. ( 2002 ) Expression of cyclooxygenase-2 in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder. Int. J. Cancer , 98 , 427 \u2013434.","DOI":"10.1002\/ijc.10222"},{"key":"key\n\t\t\t\t20171011213207_B11","doi-asserted-by":"crossref","unstructured":"Hayashi,N., Yamamoto,H., Hiraoka,N. et al . ( 2001 ) Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm. Hepatology , 34 , 638 \u2013650.","DOI":"10.1053\/jhep.2001.28198"},{"key":"key\n\t\t\t\t20171011213207_B12","unstructured":"Shacter,E. and Weitzman,S.A. ( 2002 ) Chronic inflammation and cancer. Oncology (Huntingt) , 16 , 217 \u2013226, 229."},{"key":"key\n\t\t\t\t20171011213207_B13","doi-asserted-by":"crossref","unstructured":"Kosaka,T., Miyata,A., Ihara,H., Hara,S., Sugimoto,T., Takeda,O., Takahashi,E. and Tanabe,T. ( 1994 ) Characterization of the human gene ( PTGS2 ) encoding prostaglandin-endoperoxide synthase 2. Eur. J. Biochem. , 221 , 889 \u2013897.","DOI":"10.1111\/j.1432-1033.1994.tb18804.x"},{"key":"key\n\t\t\t\t20171011213207_B14","doi-asserted-by":"crossref","unstructured":"Cox,D.G., Pontes,C., Guino,E., Navarro,M., Osorio,A., Canzian,F. and Moreno,V. ( 2004 ) Polymorphisms in prostaglandin synthase 2\/cyclooxygenase 2 (PTGS2\/COX2) and risk of colorectal cancer. Br. J. Cancer , 91 , 339 \u2013343.","DOI":"10.1038\/sj.bjc.6601906"},{"key":"key\n\t\t\t\t20171011213207_B15","doi-asserted-by":"crossref","unstructured":"Koh,W.P., Yuan,J.M., van den Berg,D., Lee,H.P. and Yu,M.C. ( 2004 ) Interaction between cyclooxygenase-2 gene polymorphism and dietary n -6 polyunsaturated fatty acids on colon cancer risk: the Singapore Chinese Health Study. Br. J. Cancer , 90 , 1760 \u20131764.","DOI":"10.1038\/sj.bjc.6601797"},{"key":"key\n\t\t\t\t20171011213207_B16","doi-asserted-by":"crossref","unstructured":"Campa,D., Zienolddiny,S., Maggini,V., Skaug,V., Haugen,A. and Canzian,F. ( 2004 ) Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer. Carcinogenesis , 25 , 229 \u2013235.","DOI":"10.1093\/carcin\/bgh008"},{"key":"key\n\t\t\t\t20171011213207_B17","doi-asserted-by":"crossref","unstructured":"Hu,Z., Miao,X., Ma,H., Wang,X., Tan,W., Wei,Q., Lin,D. and Shen,H. ( 2005 ) A common polymorphism in the 3\u2032 UTR of cyclooxygenase 2\/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population. Lung Cancer , 48 , 11 \u201317.","DOI":"10.1016\/j.lungcan.2004.09.004"},{"key":"key\n\t\t\t\t20171011213207_B18","doi-asserted-by":"crossref","unstructured":"Sorensen,M., Autrup,H., Tjonneland,A., Overvad,K. and Raaschou-Nielsen,O. ( 2005 ) A genetic polymorphism in prostaglandin synthase 2 (8473, T\u2192C) and the risk of lung cancer. Cancer Lett. , 226 , 49 \u201354.","DOI":"10.1016\/j.canlet.2005.03.037"},{"key":"key\n\t\t\t\t20171011213207_B19","doi-asserted-by":"crossref","unstructured":"Panguluri,R.C., Long,L.O., Chen,W. et al . ( 2004 ) COX-2 gene promoter haplotypes and prostate cancer risk. Carcinogenesis , 25 , 961 \u2013966.","DOI":"10.1093\/carcin\/bgh100"},{"key":"key\n\t\t\t\t20171011213207_B20","doi-asserted-by":"crossref","unstructured":"Kang,S., Kim,Y.B., Kim,M.H. et al . ( 2005 ) Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer. Cancer Lett. , 217 , 11 \u201316.","DOI":"10.1016\/j.canlet.2004.06.053"},{"key":"key\n\t\t\t\t20171011213207_B21","doi-asserted-by":"crossref","unstructured":"Packer,B.R., Yeager,M., Staats,B. et al . ( 2004 ) SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes. Nucleic Acids Res. , 32 , D528 \u2013D532.","DOI":"10.1093\/nar\/gkh005"},{"key":"key\n\t\t\t\t20171011213207_B22","doi-asserted-by":"crossref","unstructured":"Armitage,P. ( 1955 ) Tests for linear trends in proportions and frequencies. Biometrics , 11 , 375 \u2013386.","DOI":"10.2307\/3001775"},{"key":"key\n\t\t\t\t20171011213207_B23","doi-asserted-by":"crossref","unstructured":"Simes,R.J. ( 1986 ) An improved Bonferroni procedure for multiple tests of significance. Biometrika , 73 , 751 \u2013754.","DOI":"10.1093\/biomet\/73.3.751"},{"key":"key\n\t\t\t\t20171011213207_B24","doi-asserted-by":"crossref","unstructured":"Rosenberg,P.S., Che,A. and Chen,B.E. ( 2006 ) Multiple hypothesis testing strategies for genetic case\u2013control association studies. Statist. Med ., (in press).","DOI":"10.1002\/sim.2407"},{"key":"key\n\t\t\t\t20171011213207_B25","doi-asserted-by":"crossref","unstructured":"Barrett,J.C., Fry,B., Maller,J. and Daly,M.J. ( 2005 ) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics , 21 , 263 \u2013265.","DOI":"10.1093\/bioinformatics\/bth457"},{"key":"key\n\t\t\t\t20171011213207_B26","doi-asserted-by":"crossref","unstructured":"Schaid,D.J., Rowland,C.M., Tines,D.E., Jacobson,R.M. and Poland,G.A. ( 2002 ) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet. , 70 , 425 \u2013434.","DOI":"10.1086\/338688"},{"key":"key\n\t\t\t\t20171011213207_B27","unstructured":"Excoffier,L. and Slatkin,M. ( 1995 ) Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol. Biol. Evol. , 12 , 921 \u2013927."},{"key":"key\n\t\t\t\t20171011213207_B28","doi-asserted-by":"crossref","unstructured":"MacFaul,G.R. and Chapman,R.W. ( 2004 ) Sclerosing cholangitis. Curr. Opin. Gastroenterol. , 20 , 275 \u2013280.","DOI":"10.1097\/00001574-200405000-00013"},{"key":"key\n\t\t\t\t20171011213207_B29","doi-asserted-by":"crossref","unstructured":"Dixon,D.A., Kaplan,C.D., McIntyre,T.M., Zimmerman,G.A. and Prescott,S.M. ( 2000 ) Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3\u2032-untranslated region. J. Biol. Chem. , 275 , 11750 \u201311757.","DOI":"10.1074\/jbc.275.16.11750"},{"key":"key\n\t\t\t\t20171011213207_B30","doi-asserted-by":"crossref","unstructured":"Campa,D., Hung,R.J., Mates,D. et al . ( 2005 ) Lack of association between polymorphisms in inflammatory genes and lung cancer risk. Cancer Epidemiol. Biomarkers Prev. , 14 , 538 \u2013539.","DOI":"10.1158\/1055-9965.EPI-04-0513"},{"key":"key\n\t\t\t\t20171011213207_B31","doi-asserted-by":"crossref","unstructured":"Fritsche,E., Baek,S.J., King,L.M., Zeldin,D.C., Eling,T.E. and Bell,D.A. ( 2001 ) Functional characterization of cyclooxygenase-2 polymorphisms. J. Pharmacol. Exp. Ther. , 299 , 468 \u2013476.","DOI":"10.1016\/S0022-3565(24)29252-1"},{"key":"key\n\t\t\t\t20171011213207_B32","doi-asserted-by":"crossref","unstructured":"Goodman,J.E., Bowman,E.D., Chanock,S.J., Alberg,A.J. and Harris,C.C. ( 2004 ) Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis , 25 , 2467 \u20132472.","DOI":"10.1093\/carcin\/bgh260"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/27\/6\/1251\/7090303\/bgi314.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T15:46:45Z","timestamp":1736178405000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/carcin\/article\/27\/6\/1251\/2391001\/Prostaglandinendoperoxide-synthase-2-PTGS2-gene"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,16]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2005,12,16]]},"published-print":{"date-parts":[[2006,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgi314","relation":{},"ISSN":["1460-2180","0143-3334"],"issn-type":[{"type":"electronic","value":"1460-2180"},{"type":"print","value":"0143-3334"}],"subject":[],"published-other":{"date-parts":[[2006,6]]},"published":{"date-parts":[[2005,12,16]]}}}